Sermorelin vs Wegovy — Peptide vs GLP-1 for Weight Loss

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Sermorelin and Wegovy are often mentioned together in weight loss conversations, yet they work through completely different biological mechanisms. Sermorelin is a growth hormone-releasing peptide that signals the pituitary gland to produce more HGH, while Wegovy (semaglutide) activates GLP-1 receptors to reduce hunger and slow stomach emptying. Clinical evidence shows GLP-1 medications typically produce larger weight reductions in shorter timeframes, with studies demonstrating 15% to 22% body weight loss over 68 weeks.

How Sermorelin and Wegovy Work Differently in Your Body

Sermorelin functions as a secretagogue—it essentially tells your brain's pituitary gland to produce more growth hormone naturally. This indirect approach aims to boost metabolic rate, increase lean muscle, and improve body composition over months of consistent use. The peptide binds to growth hormone-releasing hormone receptors and mimics the body's own signaling patterns.

Wegovy (semaglutide) takes a direct route by binding to GLP-1 receptors located in the brain's appetite centers and throughout the digestive tract. This activation reduces hunger signals, delays gastric emptying so food stays in your stomach longer, and helps regulate blood sugar. The result is decreased caloric intake and faster weight loss—typically visible within weeks rather than months.

Weight Loss Results: What Clinical Evidence Shows

Sermorelin studies generally report modest weight loss—typically 3 to 8 pounds over 12 weeks—because it works indirectly through metabolic enhancement rather than appetite suppression. Results vary widely depending on age, baseline fitness level, and whether users combine sermorelin with exercise and calorie restriction.

Semaglutide and tirzepatide clinical trials demonstrate substantially larger reductions: participants lost 15% to 22% of body weight in the STEP trials over 68 weeks, with some reaching BMI reductions from obese to overweight categories. This difference reflects the direct appetite-suppressing mechanism, which produces more immediate and measurable outcomes for most users.

Timeline: How Quickly You'll See Results

Sermorelin requires patience. Most users notice gradual changes after 4 to 8 weeks of consistent injections, with momentum building over 3 to 6 months as HGH levels rise and muscle mass increases. Patience is necessary because growth hormone works through slower metabolic pathways.

GLP-1 medications like semaglutide produce noticeable appetite reduction within 3 to 7 days for many users, with weight loss becoming apparent on the scale within 2 to 4 weeks. This faster timeline occurs because appetite suppression creates immediate caloric deficit, whereas sermorelin's metabolic boost accumulates gradually over time.

PlexusDx Semaglutide Injection: Precision GLP-1 Therapy

PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies, with no insurance requirement and HSA/FSA eligibility. Each monthly price remains flat regardless of dose adjustments—your dose may need to go up, but your price won't, ensuring transparency and predictability throughout your treatment.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Side Effects and Safety Considerations

Sermorelin side effects are generally mild: injection site redness, facial flushing, and occasional dizziness are most common, resolving quickly in most users. Because it works indirectly through the body's own hormone production, systemic side effects are uncommon when prescribed appropriately.

GLP-1 medications produce more noticeable gastrointestinal effects—nausea, constipation, or reduced appetite for specific foods—which typically subside within 2 to 4 weeks as your body adapts. Both medication classes are well-tolerated when dosed correctly, though GLP-1 therapy's stronger appetite suppression means lifestyle adjustment is more pronounced during initial weeks.

Cost and Access: Comparing Your Options

Sermorelin from compounding pharmacies typically ranges from $100 to $200 monthly, while brand-name Wegovy costs $935 to $1,350 per month without insurance coverage. PlexusDx compounded semaglutide injection delivers GLP-1 therapy at $189/mo (or $149/mo on the 6-month plan) starting price, making clinical-grade weight loss accessible without insurance or membership fees.

PlexusDx serves all 50 states with medications from licensed 503A compounding pharmacies, eliminating the geographic limitations and insurance barriers many face with brand options. HSA and FSA accounts cover PlexusDx medications, adding another avenue for cost management that may not apply to certain competitors.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Can I use sermorelin and Wegovy together?

Combining sermorelin with GLP-1 therapy is not standard practice and lacks robust clinical evidence. Most providers recommend choosing one pathway based on your specific goals, timeline, and response profile. PlexusDx offers the GLP-Squared injection (semaglutide plus tirzepatide dual compound) as an evidence-based combination strategy at $289/mo month-to-month, or from $249/mo on the 6-month plan.

How long does sermorelin take to work compared to semaglutide?

Sermorelin typically requires 4 to 8 weeks before noticeable changes occur, with peak effects materializing after 3 to 6 months. Semaglutide produces appetite reduction within days and visible weight loss within 2 to 4 weeks, making it substantially faster for users seeking rapid results.

Is PlexusDx semaglutide FDA-approved?

PlexusDx semaglutide is compounded by licensed 503A pharmacies using FDA-approved active ingredients and pharmacy-grade standards. Compounded medications differ from brand-name products but maintain clinical quality and efficacy when created by accredited facilities.

What are the main side effects I should expect?

Sermorelin typically causes mild injection-site reactions and occasional flushing, while semaglutide commonly produces nausea, constipation, or appetite changes that usually resolve within 2 to 4 weeks. Both medications are safe when dosed appropriately, though GLP-1 therapy's gastrointestinal effects are more pronounced initially.

How does the Precision Peptide Genetic Test help me choose the right medication?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss
• Glp 1 Receptor Agonist For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.